Literature DB >> 22954220

Creative deaminases, self-inflicted damage, and genome evolution.

Silvestro G Conticello1.   

Abstract

Organisms minimize genetic damage through complex pathways of DNA repair. Yet a gene family--the AID/APOBECs--has evolved in vertebrates with the sole purpose of producing targeted damage in DNA/RNA molecules through cytosine deamination. They likely originated from deaminases involved in A>I editing in tRNAs. AID, the archetypal AID/APOBEC, is the trigger of the somatic diversification processes of the antibody genes. Its homologs may have been associated with the immune system even before the evolution of the antibody genes. The APOBEC3s, arising from duplication of AID, are involved in the restriction of exogenous/endogenous threats such as retroviruses and mobile elements. Another family member, APOBEC1, has (re)acquired the ability to target RNA while maintaining its ability to act on DNA. The AID/APOBECs have shaped the evolution of vertebrate genomes, but their ability to mutate nucleic acids is a double-edged sword: AID is a key player in lymphoproliferative diseases by triggering mutations and chromosomal translocations in B cells, and there is increasing evidence suggesting that other AID/APOBECs could be involved in cancer development as well.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954220     DOI: 10.1111/j.1749-6632.2012.06614.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

Review 2.  The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.

Authors:  Abby M Green; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2019-09-13

3.  The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.

Authors:  Qihan Chen; Xiao Xiao; Aaron Wolfe; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2016-04-08       Impact factor: 5.469

4.  Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.

Authors:  Markus-Frederik Bohn; Shivender M D Shandilya; John S Albin; Takahide Kouno; Brett D Anderson; Rebecca M McDougle; Michael A Carpenter; Anurag Rathore; Leah Evans; Ahkillah N Davis; Jingying Zhang; Yongjian Lu; Mohan Somasundaran; Hiroshi Matsuo; Reuben S Harris; Celia A Schiffer
Journal:  Structure       Date:  2013-05-16       Impact factor: 5.006

5.  Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.

Authors:  Nicholas J Haradhvala; Paz Polak; Petar Stojanov; Kyle R Covington; Eve Shinbrot; Julian M Hess; Esther Rheinbay; Jaegil Kim; Yosef E Maruvka; Lior Z Braunstein; Atanas Kamburov; Philip C Hanawalt; David A Wheeler; Amnon Koren; Michael S Lawrence; Gad Getz
Journal:  Cell       Date:  2016-01-21       Impact factor: 41.582

Review 6.  The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions.

Authors:  Kimberly M Prohaska; Ryan P Bennett; Jason D Salter; Harold C Smith
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-03-24       Impact factor: 9.957

7.  APOBEC1 mediated C-to-U RNA editing: target sequence and trans-acting factor contribution to 177 RNA editing events in 119 murine transcripts in-vivo.

Authors:  Saeed Soleymanjahi; Valerie Blanc; Nicholas Davidson
Journal:  RNA       Date:  2021-06-03       Impact factor: 5.636

8.  Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.

Authors:  Rachel A DeWeerd; Eszter Németh; Ádám Póti; Nataliya Petryk; Chun-Long Chen; Olivier Hyrien; Dávid Szüts; Abby M Green
Journal:  Cell Rep       Date:  2022-03-22       Impact factor: 9.995

Review 9.  AID/APOBEC deaminases and cancer.

Authors:  Stefan Rebhandl; Michael Huemer; Richard Greil; Roland Geisberger
Journal:  Oncoscience       Date:  2015-04-28

Review 10.  The role of cytidine deaminases on innate immune responses against human viral infections.

Authors:  Valdimara C Vieira; Marcelo A Soares
Journal:  Biomed Res Int       Date:  2013-06-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.